MUSAZZI, UMBERTO MARIA
MUSAZZI, UMBERTO MARIA
Dipartimento di Scienze Farmaceutiche
Medicines shortages in the EU: strategies to prevent and mitigate their impact
2026 U.M. Musazzi
Regulatory Challenges and Classification of Substance-Based Medical Devices under Regulation (EU) 2017/745
2026 U.M. Musazzi, S. Azari, P. Minghetti
Relevant factors to guarantee quality of oligonucleotide-based products
2026 S. Azari, S. Manellari, G. Anderluzzi, P. Minghetti, U.M. Musazzi
Arugula leaf nanovesicles as sustainable food ingredient: processing, stability, and bioavailability
2026 L. D’Adduzio, D. Marangon, U. Musazzi, G. Frigerio, G. Ranaldi, B. Lazzari, L. Sironi, R. Pugliese, M.P. Abbracchio, D. Lecca, C. Lammi
Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectives
2025 M. Khan, U.M. Musazzi, S. Manellari, N. Mouawad, G. Damiano, R. Rinaldi, A. Raucci, S. Costantino, F. Paneni, P. Minghetti, G. Pompilio, M.C. Vinci
Bio-Functional Investigation and AI-Driven Target Interaction Prediction of Chrono Control Penta as a Plant Multifunctional Dermo Cosmetic Peptide
2025 C. Lammi, R. Pugliese, L. D'Adduzio, U.M. Musazzi, G. Aiello, M. Fanzaga, M.S. Musco, C. Bollati
Skin microincision technique to enhance drug penetration for the treatment of keloid and hypertrophic scars
2025 E. Vettorato, P. Volonte, U.M. Musazzi, F. Cilurzo, A. Casiraghi
Back to gene therapy: bringing the EU regulation into the future
2025 U.M. Musazzi, P. Rocco, S. Manellari, S. Azari, G. Pompilio, P. Minghetti
Regulatory aspects of 3D printing systems in healthcare
2025 P. Minghetti, U.M. Musazzi, P. Rocco
3D printed S-protected mucoadhesive lidocaine-based orodispersible films for immediate and sustained release of the drug in paediatric therapies
2025 G.F. Racaniello, M. Totaro, C. Meazzini, A. Lopedota, A. Lopalco, R. Rizzi, U.M. Musazzi, F. Cilurzo, N. Denora
Regulatory aspects of oligonucleotides rna drugs
2024 U.M. Musazzi
Equivalence assessment of creams with quali-quantitative differences in light of the EMA and FDA regulatory framework
2024 P. Volonte', U.M. Musazzi, L. Arnaboldi, M.A. Ortenzi, A. Casiraghi, F. Cilurzo, P. Minghetti
β-galactosidase orodispersible dosage forms for the treatment of lactose intolerance
2024 U.M. Musazzi, C. Meazzini, G. Anderluzzi, G. Frigerio, F. Selmin, P. Minghetti, F. Cilurzo
Updating ‘Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance’ with Data on pig ear skin
2024 P. Volonte', U.M. Musazzi, C. Gennari, A. Casiraghi, F. Cilurzo, P. Minghetti
Patient-managed digital medical devices: Do we need further regulation?
2024 P. Minghetti, U.M. Musazzi, S. Manellari, V. Pagella, P. Rocco
Food Supplements Marketed Worldwide: A Comparative Analysis Between the European and the U.S. Regulatory Frameworks
2024 A. Zovi, A. Vitiello, M. Sabbatucci, U.M. Musazzi, G. Sagratini, C. Cifani, S. Vittori
How to assess the quality of complex drug products and their copies: the case study of semisolid preparations
2024 U.M. Musazzi, P. Volonte'
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study
2023 E. Zucchi, U.M. Musazzi, G. Fedele, I. Martinelli, G. Gianferrari, C. Simonini, N. Fini, A. Ghezzi, M. Caputo, E. Sette, V. Vacchiano, L. Zinno, P. Anceschi, E. Canali, M. Vinceti, S. Ferro, J. Mandrioli, L. Ferri, A. Gessani, R. Liguori, P. Cortelli, R. Michelucci, F. Salvi, I. Bartolomei, A.M. Borghi, A. Zini, R. Rinaldi, V. Tugnoli, M. Pugliatti, L. Codeluppi, F. Valzania, F. Stragliati, A. Nuredini, S. Romano, A. D'Orsi, L. Parrino, D. Medici, G. Pilurzi, E. Terlizzi, D. Guidetti, S. De Pasqua, M. Santangelo, P. De Massis, M. Gizzi, M. Casmiro, P. Querzani, S. Morresi, M. Vitiello, M. Longoni, A. Patuelli, S. Malagù, F. Bianchi, M.C. Dossi, C. Ganino
Feeding Next-Generation Nanomedicines to Europe: Regulatory and Quality Challenges
2023 U.M. Musazzi, S. Franze, F. Condorelli, P. Minghetti, P. Caliceti
Cases of drug repositioning in children's orphan drugs: Licenced drugs versus unlicenced magistral preparations
2023 D. Zanon, U.M. Musazzi, M. Cirino, G. Bennati, A. Casiraghi, N. Maximova, E. Barbi, P. Minghetti